Winton Group LTD Co Diagnostics, Inc. Transaction History

Winton Group LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 10, 2022	SELL	$8.12 - $10.37 $902,188 - $1.15 Million	-111,107 Closed	0 $0
Q3 2021 Oct 28, 2021	SELL	$7.48 - $11.38 $50,362 - $76,621	-6,733 Reduced 5.71%	111,107 $1.08 Million
Q2 2021 Aug 10, 2021	BUY	$7.16 - $9.56 $295,206 - $394,158	41,230 Added 53.82%	117,840 $972,000
Q1 2021 Jul 21, 2021	BUY	$8.52 - $19.21 $128,294 - $289,264	15,058 Added 24.46%	76,610 $731,000
Q4 2020 Feb 12, 2021	BUY	$9.3 - $15.19 $572,433 - $934,974	61,552 New	61,552 $572,000

4.28M

48.2K

53.3K

Ticker CODX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 33,781,000
Market Cap $26.3M
Description
Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and ...

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

Stay updated on Winton Group LTD with notifications on news.